Bunge Global SA
123.50USD
-0.3900 (-0.31%)
Consensus EPS on the street’s adjusted basis, not the filed GAAP figure — which is why the actuals here can differ from the income statement.
| Period | Consensus EPS | 90 days ago | Revisions up (30d) | Revisions down (30d) |
|---|---|---|---|---|
| Current quarter | $2.47▼ | $2.53 | 1 | 6 |
| Next quarter | $3.34▲ | $3.15 | 7 | 0 |
| Current year | $9.64▲ | $9.43 | 6 | 1 |
| Next year | $11.34▲ | $10.89 | 5 | 2 |
Beat in 4 of the last 4
| Quarter | Estimate | Actual | Surprise |
|---|---|---|---|
| 2026-06-30 | $1.94 | $2 | +0.06 (+2.9%) |
| 2026-03-31 | $0.87 | $1.83 | +0.96 (+109.4%) |
| 2025-12-31 | $1.82 | $1.99 | +0.17 (+9.6%) |
| 2025-09-30 | $1.97 | $2.27 | +0.30 (+15.3%) |
36 ratings from 13 firms
Ratings are attributed to the research firm, not to individual analysts. See every ticker.
| Firm | Action | Rating | Price Target | Date |
|---|---|---|---|---|
| Barclays | Maintained | Overweight | $145 $150 | Apr 30, 2026 |
| Barclays | Maintained | Overweight | $135 $145 | Apr 1, 2026 |
| JP Morgan | Maintained | Overweight | $130 $134 | Mar 24, 2026 |
| Morgan Stanley | Maintained | Overweight | $130 $140 | Mar 11, 2026 |
| BMO Capital | Maintained | Outperform | $130 $135 | Mar 11, 2026 |
| JP Morgan | Maintained | Overweight | $117 $130 | Feb 5, 2026 |
| Barclays | Maintained | Overweight | $120 $135 | Feb 5, 2026 |
| UBS | Maintained | Buy | $108 $145 | Feb 5, 2026 |
| Morgan Stanley | Maintained | Overweight | $120 $130 | Feb 5, 2026 |
| JP Morgan | Maintained | Overweight | $109 $117 | Jan 21, 2026 |
| Morgan Stanley | Upgraded from Equal-Weight | Overweight | $95 $120 | Dec 16, 2025 |
| B of A Securities | Maintained | Buy | $95 $112 | Dec 2, 2025 |
| Barclays | Upgraded from Equal-Weight | Overweight | $105 $120 | Nov 6, 2025 |
| Barclays | Maintained | Equal-Weight | $85 $105 | Oct 21, 2025 |
| Stephens & Co. | Maintained | Overweight | $85 $115 | Oct 17, 2025 |
| BMO Capital | Maintained | Outperform | $95 $110 | Oct 16, 2025 |
| JP Morgan | Maintained | Overweight | $95 $107 | Oct 16, 2025 |
| Morgan Stanley | Maintained | Equal-Weight | $74 $83 | Aug 12, 2025 |
| Stephens & Co. | Maintained | Overweight | $90 $85 | May 8, 2025 |
| Citigroup | Maintained | Neutral | $76 $77 | Apr 15, 2025 |
| Morgan Stanley | Maintained | Equal-Weight | $90 $74 | Feb 11, 2025 |
| B of A Securities | Maintained | Buy | $105 $87 | Feb 11, 2025 |
| Barclays | Maintained | Equal-Weight | $95 $85 | Feb 6, 2025 |
| Barclays | Downgraded from Overweight | Equal-Weight | $115 $95 | Jan 21, 2025 |
| Citigroup | Downgraded from Buy | Neutral | $125 $114 | Aug 1, 2024 |
166 filings from 39 insiders · 0 buy / 0 sell over 6m
Officers and directors of BG, from the last two years of filings. Grants, gifts and option exercises are shown but not colour-coded — they are compensation, not a view on the price.
| Insider | Action | Shares | Price | Value | Date |
|---|---|---|---|---|---|
| Isman AdrianDirector | Grant | 10 | $119.25 | $1k | Sep 1, 2026 |
| Dimopoulos ChristosOfficer, EVP and CSO | Grant | 160 | $119.25 | $19k | Sep 1, 2026 |
| McGurk Monica HouleDirector | Grant | 10 | $119.25 | $1k | Sep 1, 2026 |
| Sears KellieOfficer, Chief Human Resources Officer | Grant | 117 | $119.25 | $14k | Sep 1, 2026 |
| Zenuk Mark NDirector | Grant | 20 | $119.25 | $2k | Sep 1, 2026 |
| Podwika JosephOfficer, Chief Legal Officer | Grant | 139 | $119.25 | $17k | Sep 1, 2026 |
| HECKMAN GREGORY ADirector; Officer, Chief Executive Officer | Grant | 992 | $119.25 | $118k | Sep 1, 2026 |
| Browner Carol M.Director | Grant | 10 | $119.25 | $1k | Sep 1, 2026 |
| Jojo Linda PDirector | Grant | 10 | $119.25 | $1k | Sep 1, 2026 |
| WINSHIP HENRY WARD IVDirector | Grant | 10 | $119.25 | $1k | Sep 1, 2026 |
| Simmons Jerry Matthews JROfficer, Controller, Principal Actg Off | Grant | 55 | $119.25 | $7k | Sep 1, 2026 |
| Lustosa de Andrade Eliane AleixoDirector | Grant | 10 | $119.25 | $1k | Sep 1, 2026 |
| Simril KennethDirector | Grant | 10 | $119.25 | $1k | Sep 1, 2026 |
| Mahoney ChristopherDirector | Grant | 10 | $119.25 | $1k | Sep 1, 2026 |
| Jensen AnneDirector | Grant | 10 | $119.25 | $1k | Sep 1, 2026 |
| Garros JulioOfficer, Chief Operating Officer | Grant | 253 | $119.25 | $30k | Sep 1, 2026 |
| Walt MarkusDirector | Grant | 10 | $119.25 | $1k | Sep 1, 2026 |
| Neppl John WOfficer, Chief Financial Officer | Grant | 253 | $119.25 | $30k | Sep 1, 2026 |
| MAHONEY CHRISTOPHERDirector | Buy | 6.5k | $105.53 | $689k | Aug 4, 2026 |
| GARROS JULIOChief Operating Officer | Grant | 237 | $126.92 | $30k | Jun 1, 2026 |
No analyst notes on BG yet.
Analyst Ratings
9 analysts covering
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Consensus |
|---|---|---|---|---|---|---|
| Current | 3 | 5 | 1 | 0 | 0 | Buy1.78 |
| 1 mo ago | 3 | 5 | 1 | 0 | 0 | Buy1.78 |
| 2 mo ago | 3 | 5 | 1 | 0 | 0 | Buy1.78 |